This conference centers on an ED consult for possible measles in a patient who developed a mild maculopapular/acneiform rash about two weeks after MMR vaccination. The case walks through the timing of symptoms, lack of classic measles features such as fever, cough, conjunctivitis, and Koplik spots, and the challenge of deciding how aggressively to isolate and test when measles is plausible but not convincing.
The teaching portion reviews expected post-MMR reactions, vaccine-associated rash illness, the CDC clinical case definition for measles, and the limitations of routine serology and RT-PCR in distinguishing vaccine-strain from wild-type measles. It highlights the role of genotyping or vaccine-strain–specific assays when available, and frames the practical tension between avoiding unnecessary public health responses and not missing true measles.